1. Academic Validation
  2. Comparison of cRGDfK Peptide Probes with Appended Shielded Heptamethine Cyanine Dye ( s775z) for Near Infrared Fluorescence Imaging of Cancer

Comparison of cRGDfK Peptide Probes with Appended Shielded Heptamethine Cyanine Dye ( s775z) for Near Infrared Fluorescence Imaging of Cancer

  • ACS Omega. 2021 Oct 30;6(44):30130-30139. doi: 10.1021/acsomega.1c04991.
Rananjaya S Gamage 1 Dong-Hao Li 1 Cynthia L Schreiber 1 Bradley D Smith 1
Affiliations

Affiliation

  • 1 Department of Chemistry and Biochemistry, University of Notre Dame, 251 Nieuwland Science Hall, Notre Dame, Indiana 46556-5670, United States.
Abstract

Previous work has shown that the sterically shielded near-infrared (NIR) fluorescent heptamethine cyanine dye, s775z, with a reactive carboxyl group produces fluorescent bioconjugates with an unsurpassed combination of high photostability and fluorescence brightness. This present contribution reports two new reactive homologues of s775z with either a maleimide group for reaction with a thiol or a strained alkyne group for reaction with an azide. Three cancer-targeting NIR fluorescent probes were synthesized, each with an appended cRGDfK peptide to provide selective affinity for Integrin receptors that are overexpressed on the surface of many Cancer cells including the A549 lung adenocarcinoma cells used in this study. A set of Cancer cell microscopy and mouse tumor imaging experiments showed that all three probes were very effective at targeting Cancer cells and tumors; however, the change in the linker structure produced a statistically significant difference in some aspects of the mouse biodistribution. The mouse studies included a mock surgical procedure that excised the subcutaneous tumors. A paired-agent fluorescence imaging experiment co-injected a binary mixture of targeted probe with 850 nm emission, an untargeted probe with 710 nm emission and determined the targeted probe's binding potential in the tumor tissue. A comparison of pixelated maps of binding potential for each excised tumor indicated a tumor-to-tumor variation of Integrin expression levels, and a heterogeneous spatial distribution of Integrin receptors within each tumor.

Figures
Products